The Japanese Embassy in Kathmandu said in a statement on Tuesday that Motegi Toshimitsu, Japan’s Minister of Foreign Affairs, announced the relief on Tuesday.
According to the Embassy, the exact delivery timeline will be verified after the procurement agreement is concluded by the international body in charge of the subject.
The Ambassador of Japan to Nepal, Kikuta Yutaka, noted that this is a reflection of Nepal’s long-standing friendship with Japan.
“He applauded Tokyo’s decision, since the vaccination is desperately needed to save the lives of many Nepalis. According to the statement, “Ambassador is hoping that this vaccine would alleviate many issues caused by the Covid-19 situation.”
Those AstraZeneca vaccines created in Japan will successfully aid the second vaccination of older persons who have already received Covishield, an AstraZeneca-type vaccine produced by the Serum Institute of India. After India failed to supply a million doses of vaccines that Nepal had already paid for, nearly 1.4 million elderly individuals have been denied the second dosage of Covishield vaccine.
The Embassy expressed its optimism that this vaccination assistance will save the lives of many Nepali people affected by Covid-19, and that it strongly supports the immunization program, which is critical for the advancement of Nepali society and economy post-Covid.